Assay devices and methods of use thereof

US12172169B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12172169-B2
Application numberUS-202318320362-A
CountryUS
Kind codeB2
Filing dateMay 19, 2023
Priority dateAug 31, 2017
Publication dateDec 24, 2024
Grant dateDec 24, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems, methods, and apparatuses are provided for self-contained nucleic acid preparation, amplification, and analysis.

First claim

Opening claim text (preview).

What is claimed is: 1. A self-contained reaction vessel, the self-contained reaction vessel comprising: a sample lysis zone configured for lysis of cells or spores present in a sample, a first reaction zone fluidly connected to the sample lysis zone, the first reaction zone configured for recovering nucleic acids from a lysed sample and for first-stage amplification of nucleic acids present in the first reaction zone, a second-stage reaction zone fluidly connected to the first reaction zone but separate from the first reaction zone, the second-stage reaction zone comprising a plurality of second-stage reaction wells, each second-stage reaction well comprising a pair of primers configured for further amplification of the sample, the second stage reaction zone configured for contemporaneous thermal cycling of all of the plurality of second-stage reaction chambers wells, and a plurality of liquid reagent blisters fluidly connected to one or more of the sample lysis zone, the first reaction zone, or the second-stage reaction zone, wherein liquid reagents are provided in the liquid reagent blisters at time of manufacture, wherein the self-contained reaction vessel comprises a first flexible barrier film layer at least partially bonded to a second flexible barrier film layer with the sample lysis zone, first reaction zone, second-stage reaction zone, and the plurality of liquid reagent blisters comprising open spaces between the first and second flexible barrier film layers, wherein the first and second flexible barrier film layers have a water vapor transmission rate (WVTR) in a range of about 0.05 g/m 2 /24 hrs to about 2 g/m 2 /24 hrs. 2. The self-contained reaction vessel of claim 1 further comprising an openable seal between the liquid reagent disposed in the liquid reagent blister and one or more of the sample lysis zone, the first reaction zone, or the second-stage reaction zone. 3. The self-contained reaction vessel of claim 2 , wherein the openable seal is a burstable seal. 4. The self-contained reaction vessel of claim 2 , wherein the openable seal is a tacked together film seal. 5. The self-contained reaction vessel of claim 1 wherein the sample lysis zone is provided with lysis particles configured for lysing cells or spores located in the sample and magnetic beads configured for recovering nucleic acids from a lysate. 6. The self-contained reaction vessel of claim 5 , wherein the lysis particles, magnetic beads, and a lysis buffer are provided in one or more of the liquid reagent blisters that are fluidly connected to the sample lysis zone. 7. The self-contained reaction vessel of claim 6 , wherein one or more of the liquid reagent blisters fluidly connected to the first reaction zone comprise magnetic bead wash components and an elution buffer for elution of nucleic acids from the magnetic beads. 8. The self-contained reaction vessel of claim 7 , wherein one or more of the liquid reagent blisters fluidly connected to the first reaction zone comprise nucleic acid amplification components. 9. The self-contained reaction vessel of claim 1 , further comprising a sample receiving chamber in fluid communication with the sample lysis zone. 10. The self-contained reaction vessel of claim 9 , wherein the sample receiving chamber is configured to receive a sample collection swab. 11. The self-contained reaction vessel of claim 1 , wherein the first layer is a clear barrier film and the second layer is a metallized barrier film.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12172169B2 cover?
Systems, methods, and apparatuses are provided for self-contained nucleic acid preparation, amplification, and analysis.
Who is the assignee on this patent?
Biofire Defense Llc, Biofire Diagnostics Llc, Biomerieux Sa
What technology area does this patent fall under?
Primary CPC classification B01L3/502761. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).